Any current/future capex/capital investment/strategic investment?

Mastek is heavily investing in AI, focusing on both AI-for-technology (improving productivity and efficiency in technology services) and AI-for-business (delivering AI-led business transformation solutions). The company is investing in building solutions, assets, and proof of concepts in AI, with about a dozen engagements underway to build AI-for-business roadmaps for mid-market customers. Investments include hiring new leadership and strengthening capabilities, especially in North America, to drive growth in healthcare and life sciences. The firm is making targeted investments in healthcare v

Any current/future new fundraising through debt or equity?

There is no mention of any current or planned new fundraising through debt or equity in the provided transcript. The company’s focus is on operational efficiency, AI-driven growth, and executing business strategies rather than raising new capital. A candidate for the Chief Financial Officer position is expected to join early next month, which may strengthen financial management going forward. The management emphasizes strong bottom-line performance and investment in growth areas like AI, but does not indicate plans for external financing at this time.

Future growth expectations in sales/revenue/volumes?

Mastek expects significant overall services growth driven by AI investments. Short-term uncertainties and decision-making delays exist, but strong optimism about AI-led technology disruption remains. North America is projected to see growth, especially in healthcare and life sciences, with improving order book to revenue conversion. U.K. maintains a strong position with sizable multi-year renewals in secured government services and private sector growth. AMEA region focused on profitable growth, especially in healthcare with multi-million-dollar AI-led transformation deals. AI for technology d

Future growth expectations in earnings/operating earnings/profits/EPS?

Mastek anticipates steady and positive growth in H2 FY26 despite macro and global uncertainties (Page 14). Operational EBITDA improved 6% QoQ and 1.7% YoY in Q2, with margins increasing by 50 bps, indicating margin expansion potential (Page 2). Revenue per resource is expected to rise due to AI-driven efficiency gains, supporting margin improvement (Page 13). North America segment is poised for growth; approaching a $28-30 million run rate may lead to double-digit EBIT margins (Page 12). Company is focused on AI-led business transformation opportunities to drive disproportionate growth (Page 1

Current/ Expected Orderbook/ Pending Orders?

Mastek's 12-month order backlog as of Q2 FY'26 stood at approximately $280 million, reflecting a 2.2% sequential growth and a 6.8% year-on-year growth. Order book mix for the quarter is disproportionately high from the U.K./Europe business, which involves significant long-term contracts. In North America, shorter-term contracts are more common recently, with clients preferring 6-month to 1-year deals instead of 3- to 5-year deals, causing order book growth to be muted but possibly improving revenue conversion ratios. The overall order book growth rate has slowed down to about 7% year-on-

IN US

Sale is live|00:00:00left today

Mastek LtdQ3 FY25IT - Software

Mastek Ltd Q3 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,575P/E: 11.3Market Cap: ₹4.8K CrSector: IT - Software

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

→Mastek expects significant overall services growth driven by AI investments.
→Short-term uncertainties and decision-making delays exist, but strong optimism about AI-led technology disruption remains.
→North America is projected to see growth, especially in healthcare and life sciences, with improving order book to revenue conversion.
→U.K. maintains a strong position with sizable multi-year renewals in secured government services and private sector growth.
→AMEA region focused on profitable growth, especially in healthcare with multi-million-dollar AI-led transformation deals.
→AI for technology drives efficiency gains allowing higher revenue per resource; AI for business expected to fuel large future transformations starting FY '27.
→Operational efficiencies and AI-led delivery improvements are expected to enhance margins and bottom-line performance.
→Overall, a positive outlook with expectations of good growth in H2 2025 and beyond.

Margin guidance

Category 3

→Mastek anticipates steady and positive growth in H2 FY26 despite macro and global uncertainties (Page 14).
→Operational EBITDA improved 6% QoQ and 1.7% YoY in Q2, with margins increasing by 50 bps, indicating margin expansion potential (Page 2).
→Revenue per resource is expected to rise due to AI-driven efficiency gains, supporting margin improvement (Page 13).
→North America segment is poised for growth; approaching a $28-30 million run rate may lead to double-digit EBIT margins (Page 12).
→Company is focused on AI-led business transformation opportunities to drive disproportionate growth (Page 14).
→Shorter-term contracts in North America could lead to improved order book to revenue conversion ratios, supporting revenue growth (Page 12).
→Prudent reinvestment of efficiency gains into AI and business innovations might moderate short-term margins but support long-term profitability (Page 13).

3 more insights locked — sign up free to unlock

Fundraise plans

→There is no mention of any current or planned new fundraising through debt or equity in the provided transcript.
→The company’s focus is on operational efficiency, AI-driven growth, and executing business strategies rather than raising new capital.
→A candidate for the Chief Financial Officer position is expected to join early next month, which may strengthen financial management going forward.
→The management emphasizes strong bottom-line performance and investment in growth areas like AI, but does not indicate plans for external financing at this time.

Order book

→Mastek's 12-month order backlog as of Q2 FY'26 stood at approximately $280 million, reflecting a 2.2% sequential growth and a 6.8% year-on-year growth.
→Order book mix for the quarter is disproportionately high from the U.K./Europe business, which involves significant long-term contracts.
→In North America, shorter-term contracts are more common recently, with clients preferring 6-month to 1-year deals instead of 3- to 5-year deals, causing order book growth to be muted but possibly improving revenue conversion ratios.
→The overall order book growth rate has slowed down to about 7% year-on-year, partly due to delayed decision-making and clients evaluating AI impacts on budgets.
→No regional bifurcation of order book is disclosed routinely; instead, regional performance and outlook are shared.
→One-off deal revenue of around $0.5 million is expected to be recognized in future quarters.

Capex plans

Yes

→Mastek is heavily investing in AI, focusing on both AI-for-technology (improving productivity and efficiency in technology services) and AI-for-business (delivering AI-led business transformation solutions).
→The company is investing in building solutions, assets, and proof of concepts in AI, with about a dozen engagements underway to build AI-for-business roadmaps for mid-market customers.
→Investments include hiring new leadership and strengthening capabilities, especially in North America, to drive growth in healthcare and life sciences.
→The firm is making targeted investments in healthcare verticals, especially in the APAC and Middle East regions.
→While pursuing efficiency gains that partly flow back to customers, Mastek is also reinvesting some of these savings into growth areas such as AI transformation.
→Operational efficiency improvements across delivery and G&A functions are ongoing but not currently quantified.

How does Mastek Ltd rank vs peers in IT - Software?

Pro feature

1Mastek Ltd

Rev 4Mar 3

See full IT - Software sector rankings

Want more stocks like Mastek Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio